SCHEMBL1462038

SCHEMBL1462038

CC(Cl)(C=O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7667187 0.77
SCHEMBL6445712 0.74
SCHEMBL2417781 0.72 ALDH1A1 (0.38)
Dalapon SCHEMBL4895986 0.70 TSHR (0.57)
SCHEMBL1678472 0.70 TSHR (0.57)
Dalapon SCHEMBL45164 0.70
SCHEMBL301323 0.70
SCHEMBL8384669 0.69 TSHR (0.44)
SCHEMBL1289474 0.69
SCHEMBL1255436 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2796442-A1 CAJANINE STRUCTURE ANALOGOUS COMPOUND, PREPARATION METHOD AND USE Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences (CN) 2014-10-29 EP disclosed
US-20110070657-A1 DETECTING IONS AND MEASURING ION CONCENTRATIONS THE GENERAL HOSPITAL CORPORATION (US) 2011-03-24 US disclosed
WO-2009026251-A1 DETECTING IONS AND MEASURING ION CONCENTRATIONS THE GENERAL HOSPITAL CORPORATION (US) 2009-02-26 WO disclosed
EP-1208097-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS Aventis Pharmaceuticals Inc. (US) 2002-05-29 EP disclosed
WO-2001007436-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS AVENTIS PHARMACEUTICALS INC. (US) 2001-02-01 WO disclosed
EP-0006114-B1 7-METHOXY-5-OXO-5H-THIAZOLO(2,3-B)QUINAZOLIN-2-CARBOXYLIC ACID AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS, PROCESS FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1982-04-07 EP disclosed
EP-0006114-A1 7-Methoxy-5-oxo-5H-thiazolo(2,3-b)quinazolin-2-carboxylic acid and its pharmaceutically acceptable salts, process for their preparation and medicines containing them F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1980-01-09 EP disclosed